{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Other|NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.4891</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>Spain</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>Portugal</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>Pakistan</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "      Status         Study Results Conditions  \\\n",
       "0  Completed  No Results Available   COVID-19   \n",
       "1  Completed           Has Results   COVID-19   \n",
       "2  Completed  No Results Available   COVID-19   \n",
       "3  Completed  No Results Available   COVID-19   \n",
       "4  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures Gender  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...    All   \n",
       "1  Change From Baseline in C-reactive Protein (CR...    All   \n",
       "2  To calulate the time of intubation|To calculat...    All   \n",
       "3  Differences in gut microbiota composition betw...    All   \n",
       "4  Percentage of subjects with COVID-19 disease p...    All   \n",
       "\n",
       "                                           Age   Phases  Enrollment  \\\n",
       "0    18 Years and older   (Adult, Older Adult)  Phase 2          17   \n",
       "1  18 Years to 70 Years   (Adult, Older Adult)  Phase 2         206   \n",
       "2    18 Years and older   (Adult, Older Adult)  Phase 2         495   \n",
       "3    18 Years and older   (Adult, Older Adult)      NaN         115   \n",
       "4    18 Years and older   (Adult, Older Adult)  Phase 3         152   \n",
       "\n",
       "       Funded Bys      Study Type Start Date Completion Date First Posted  \\\n",
       "0       Other|NIH  Interventional   1-Jun-20       22-Jan-21    11-Jun-20   \n",
       "1  Industry|Other  Interventional  21-Jul-20       13-Oct-20    30-Jun-20   \n",
       "2  Other|Industry  Interventional  22-May-20       23-Dec-20    24-Jun-20   \n",
       "3           Other   Observational  20-Apr-20       16-Jul-20    21-Apr-20   \n",
       "4           Other  Interventional  29-Sep-20       15-Apr-21     8-Oct-20   \n",
       "\n",
       "         Locations p-values  \n",
       "0    United States      NaN  \n",
       "1   United Kingdom   0.4891  \n",
       "2            Spain      NaN  \n",
       "3         Portugal      NaN  \n",
       "4         Pakistan      NaN  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# File to Load (Remember to Change These)\n",
    "covid = \"covid-clinical-trial_data_cleandata.csv\"\n",
    "\n",
    "# Read Purchasing File and store into Pandas data frame\n",
    "covid_df = pd.read_csv(covid)\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>Spain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Observational</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>Portugal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>Pakistan</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "      Status Conditions                                      Interventions  \\\n",
       "0  Completed   COVID-19                                   Drug: Infliximab   \n",
       "1  Completed   COVID-19                            Drug: C21|Drug: Placebo   \n",
       "2  Completed   COVID-19                                  Drug: Tocilizumab   \n",
       "3  Completed   COVID-19                                    Other: Exposure   \n",
       "4  Completed   COVID-19  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "  Gender                                          Age   Phases  Enrollment  \\\n",
       "0    All    18 Years and older   (Adult, Older Adult)  Phase 2          17   \n",
       "1    All  18 Years to 70 Years   (Adult, Older Adult)  Phase 2         206   \n",
       "2    All    18 Years and older   (Adult, Older Adult)  Phase 2         495   \n",
       "3    All    18 Years and older   (Adult, Older Adult)      NaN         115   \n",
       "4    All    18 Years and older   (Adult, Older Adult)  Phase 3         152   \n",
       "\n",
       "       Study Type Start Date Completion Date        Locations  \n",
       "0  Interventional   1-Jun-20       22-Jan-21    United States  \n",
       "1  Interventional  21-Jul-20       13-Oct-20   United Kingdom  \n",
       "2  Interventional  22-May-20       23-Dec-20            Spain  \n",
       "3   Observational  20-Apr-20       16-Jul-20         Portugal  \n",
       "4  Interventional  29-Sep-20       15-Apr-21         Pakistan  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#columns to delete\n",
    "remove_columns = covid_df.drop(columns=['Study Results','Outcome Measures','Funded Bys','First Posted','p-values'])\n",
    "remove_columns.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1123"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Checking the number of studies\n",
    "trial_count = covid_df[\"NCT Number\"].count()\n",
    "trial_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "511"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Count phases\n",
    "phase_count = covid_df[\"Phases\"].count()\n",
    "phase_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<bound method Series.count of 0         United States\n",
       "1        United Kingdom\n",
       "2                 Spain\n",
       "3              Portugal\n",
       "4              Pakistan\n",
       "             ...       \n",
       "1118             Turkey\n",
       "1119          Argentina\n",
       "1120             Turkey\n",
       "1121             France\n",
       "1122             Israel\n",
       "Name: Locations, Length: 1123, dtype: object>"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Count Countries\n",
    "Countries_count = covid_df[\"Locations\"].count\n",
    "Countries_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>6</td>\n",
       "      <td>NCT04466644</td>\n",
       "      <td>COVID-19: A Prevalence Study of Two ART Centre...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Diagnostic Test: ELISA|Diagnostic Test: RT-PCR</td>\n",
       "      <td>Prevalence of contagiousness in asymptomatic i...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>340</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>8-Jun-20</td>\n",
       "      <td>25-Aug-20</td>\n",
       "      <td>10-Jul-20</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>9</td>\n",
       "      <td>NCT04404179</td>\n",
       "      <td>Setting up a COVID-19 Care Facility at a Priso...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: COVID-19 FACILITY</td>\n",
       "      <td>Recovery|Mortality|ICU admission</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>27-Mar-20</td>\n",
       "      <td>2-May-20</td>\n",
       "      <td>27-May-20</td>\n",
       "      <td>Pakistan</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>11</td>\n",
       "      <td>NCT04389658</td>\n",
       "      <td>Contagiousness and Immunogenicity Status of CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Prevalence of contagiousness in asymptomatic i...</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1526</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>7-May-20</td>\n",
       "      <td>25-Aug-20</td>\n",
       "      <td>15-May-20</td>\n",
       "      <td>Spain</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>13</td>\n",
       "      <td>NCT04392141</td>\n",
       "      <td>Colchicine Plus Phenolic Monoterpenes to Treat...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard Treatment|Drug: Oral administra...</td>\n",
       "      <td>Mortality Rate|SpO2|Length of Hospitalization|...</td>\n",
       "      <td>All</td>\n",
       "      <td>10 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>120</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Apr-20</td>\n",
       "      <td>1-Nov-20</td>\n",
       "      <td>18-May-20</td>\n",
       "      <td>Islamic Republic of</td>\n",
       "      <td>0.0318</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>15</td>\n",
       "      <td>NCT04449718</td>\n",
       "      <td>Vitamin D Supplementation in Patients With COV...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Dietary Supplement: Vitamin D|Dietary Suppleme...</td>\n",
       "      <td>Length of hospitalization|Mortality|Number of ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>240</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>7-Oct-20</td>\n",
       "      <td>29-Jun-20</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1118</th>\n",
       "      <td>1119</td>\n",
       "      <td>NCT04407000</td>\n",
       "      <td>Bioequivalence Study of Favipiravir 200 mg Fil...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Bioequivalence</td>\n",
       "      <td>Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug:...</td>\n",
       "      <td>Primary PK End Points AUC0-tlast|Primary PK En...</td>\n",
       "      <td>Male</td>\n",
       "      <td>20 Years to 40 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>23-Jun-20</td>\n",
       "      <td>8-Aug-20</td>\n",
       "      <td>29-May-20</td>\n",
       "      <td>Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1119</th>\n",
       "      <td>1120</td>\n",
       "      <td>NCT04763304</td>\n",
       "      <td>Self-contamination Following Removal of Two Pe...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Personal Protective Equipment|Self Contamination</td>\n",
       "      <td>Other: Gown personal protective equipment (PPE...</td>\n",
       "      <td>Mean within-participant difference in self-con...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>60</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Sep-20</td>\n",
       "      <td>18-Nov-20</td>\n",
       "      <td>21-Feb-21</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1120</th>\n",
       "      <td>1121</td>\n",
       "      <td>NCT04386876</td>\n",
       "      <td>Bioequivalence Study of Lopinavir/Ritonavir 20...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Bioequivalence</td>\n",
       "      <td>Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Ta...</td>\n",
       "      <td>Primary PK End Points</td>\n",
       "      <td>Male</td>\n",
       "      <td>20 Years to 40 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>30-Apr-20</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>13-May-20</td>\n",
       "      <td>Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1121</th>\n",
       "      <td>1122</td>\n",
       "      <td>NCT04621552</td>\n",
       "      <td>Virtual Simulation for Woven EndoBridge Device...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Aneurysm|Intracranial Aneurysm</td>\n",
       "      <td>Device: WEB embolization</td>\n",
       "      <td>Median duration of the intervention|Median rad...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>186</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>1-Jan-15</td>\n",
       "      <td>30-Oct-20</td>\n",
       "      <td>9-Nov-20</td>\n",
       "      <td>France</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1122</th>\n",
       "      <td>1123</td>\n",
       "      <td>NCT04761510</td>\n",
       "      <td>Mindfulness-SOS: Stress Reduction for Refugees</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Stress Disorders, Post-Traumatic|Stress Relate...</td>\n",
       "      <td>Behavioral: Mindfulness-SOS for Refugees</td>\n",
       "      <td>Harvard Trauma Questionnaire according to DSM-...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>60</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>14-Sep-20</td>\n",
       "      <td>14-Jan-21</td>\n",
       "      <td>21-Feb-21</td>\n",
       "      <td>Israel</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1047 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Rank   NCT Number                                              Title  \\\n",
       "5        6  NCT04466644  COVID-19: A Prevalence Study of Two ART Centre...   \n",
       "8        9  NCT04404179  Setting up a COVID-19 Care Facility at a Priso...   \n",
       "10      11  NCT04389658  Contagiousness and Immunogenicity Status of CO...   \n",
       "12      13  NCT04392141  Colchicine Plus Phenolic Monoterpenes to Treat...   \n",
       "14      15  NCT04449718  Vitamin D Supplementation in Patients With COV...   \n",
       "...    ...          ...                                                ...   \n",
       "1118  1119  NCT04407000  Bioequivalence Study of Favipiravir 200 mg Fil...   \n",
       "1119  1120  NCT04763304  Self-contamination Following Removal of Two Pe...   \n",
       "1120  1121  NCT04386876  Bioequivalence Study of Lopinavir/Ritonavir 20...   \n",
       "1121  1122  NCT04621552  Virtual Simulation for Woven EndoBridge Device...   \n",
       "1122  1123  NCT04761510     Mindfulness-SOS: Stress Reduction for Refugees   \n",
       "\n",
       "         Status         Study Results  \\\n",
       "5     Completed  No Results Available   \n",
       "8     Completed  No Results Available   \n",
       "10    Completed  No Results Available   \n",
       "12    Completed           Has Results   \n",
       "14    Completed  No Results Available   \n",
       "...         ...                   ...   \n",
       "1118  Completed  No Results Available   \n",
       "1119  Completed  No Results Available   \n",
       "1120  Completed  No Results Available   \n",
       "1121  Completed  No Results Available   \n",
       "1122  Completed  No Results Available   \n",
       "\n",
       "                                             Conditions  \\\n",
       "5                                              COVID-19   \n",
       "8                                              COVID-19   \n",
       "10                                             COVID-19   \n",
       "12                                             COVID-19   \n",
       "14                                             COVID-19   \n",
       "...                                                 ...   \n",
       "1118                                     Bioequivalence   \n",
       "1119   Personal Protective Equipment|Self Contamination   \n",
       "1120                                     Bioequivalence   \n",
       "1121                     Aneurysm|Intracranial Aneurysm   \n",
       "1122  Stress Disorders, Post-Traumatic|Stress Relate...   \n",
       "\n",
       "                                          Interventions  \\\n",
       "5        Diagnostic Test: ELISA|Diagnostic Test: RT-PCR   \n",
       "8                              Other: COVID-19 FACILITY   \n",
       "10                                                  NaN   \n",
       "12    Drug: Standard Treatment|Drug: Oral administra...   \n",
       "14    Dietary Supplement: Vitamin D|Dietary Suppleme...   \n",
       "...                                                 ...   \n",
       "1118  Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug:...   \n",
       "1119  Other: Gown personal protective equipment (PPE...   \n",
       "1120  Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Ta...   \n",
       "1121                           Device: WEB embolization   \n",
       "1122           Behavioral: Mindfulness-SOS for Refugees   \n",
       "\n",
       "                                       Outcome Measures Gender  \\\n",
       "5     Prevalence of contagiousness in asymptomatic i...    All   \n",
       "8                      Recovery|Mortality|ICU admission    All   \n",
       "10    Prevalence of contagiousness in asymptomatic i...    All   \n",
       "12    Mortality Rate|SpO2|Length of Hospitalization|...    All   \n",
       "14    Length of hospitalization|Mortality|Number of ...    All   \n",
       "...                                                 ...    ...   \n",
       "1118  Primary PK End Points AUC0-tlast|Primary PK En...   Male   \n",
       "1119  Mean within-participant difference in self-con...    All   \n",
       "1120                              Primary PK End Points   Male   \n",
       "1121  Median duration of the intervention|Median rad...    All   \n",
       "1122  Harvard Trauma Questionnaire according to DSM-...    All   \n",
       "\n",
       "                                                   Age           Phases  \\\n",
       "5            18 Years and older   (Adult, Older Adult)              NaN   \n",
       "8                            Child, Adult, Older Adult              NaN   \n",
       "10                           Child, Adult, Older Adult              NaN   \n",
       "12    10 Years and older   (Child, Adult, Older Adult)  Phase 1|Phase 2   \n",
       "14           18 Years and older   (Adult, Older Adult)   Not Applicable   \n",
       "...                                                ...              ...   \n",
       "1118                    20 Years to 40 Years   (Adult)          Phase 1   \n",
       "1119         18 Years and older   (Adult, Older Adult)   Not Applicable   \n",
       "1120                    20 Years to 40 Years   (Adult)          Phase 1   \n",
       "1121         18 Years and older   (Adult, Older Adult)              NaN   \n",
       "1122       18 Years to 65 Years   (Adult, Older Adult)   Not Applicable   \n",
       "\n",
       "      Enrollment      Funded Bys      Study Type Start Date Completion Date  \\\n",
       "5            340        Industry   Observational   8-Jun-20       25-Aug-20   \n",
       "8             69           Other   Observational  27-Mar-20        2-May-20   \n",
       "10          1526        Industry   Observational   7-May-20       25-Aug-20   \n",
       "12           120           Other  Interventional   1-Apr-20        1-Nov-20   \n",
       "14           240           Other  Interventional   1-Jun-20        7-Oct-20   \n",
       "...          ...             ...             ...        ...             ...   \n",
       "1118          30  Industry|Other  Interventional  23-Jun-20        8-Aug-20   \n",
       "1119          60           Other  Interventional   1-Sep-20       18-Nov-20   \n",
       "1120          30  Industry|Other  Interventional  30-Apr-20       11-Jun-20   \n",
       "1121         186           Other   Observational   1-Jan-15       30-Oct-20   \n",
       "1122          60           Other  Interventional  14-Sep-20       14-Jan-21   \n",
       "\n",
       "     First Posted             Locations p-values  \n",
       "5       10-Jul-20         United States      NaN  \n",
       "8       27-May-20              Pakistan      NaN  \n",
       "10      15-May-20                 Spain      NaN  \n",
       "12      18-May-20   Islamic Republic of   0.0318  \n",
       "14      29-Jun-20                Brazil      NaN  \n",
       "...           ...                   ...      ...  \n",
       "1118    29-May-20                Turkey      NaN  \n",
       "1119    21-Feb-21             Argentina      NaN  \n",
       "1120    13-May-20                Turkey      NaN  \n",
       "1121     9-Nov-20                France      NaN  \n",
       "1122    21-Feb-21                Israel      NaN  \n",
       "\n",
       "[1047 rows x 19 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "# check any duplicate trials by NCT number that shows up for NCT Number and Phases. \n",
    "#duplicate_rows = covid_trial_df[covid_trial_df.duplicated(['NCT Number', 'Phases' ])]\n",
    "#duplicate_rows\n",
    "duplicate_rows = covid_df[covid_df.duplicated(['Locations'])]\n",
    "duplicate_rows\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Bar Grapth Testing for reference\n",
    "# Create an array that contains the number of Phases\n",
    "#Phases = [0, 1, 2, 3, 4]\n",
    "#x_axis = np.arange(len(Phases))\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "#plt.bar(x_axis, Phases, color='r', alpha=0.5, align=\"center\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Locations</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT03852537</th>\n",
       "      <th>Phase 2</th>\n",
       "      <th>44</th>\n",
       "      <th>15-Mar-21</th>\n",
       "      <th>United States</th>\n",
       "      <td>1100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04160975</th>\n",
       "      <th>Not Applicable</th>\n",
       "      <th>2902</th>\n",
       "      <th>19-Feb-21</th>\n",
       "      <th>United States</th>\n",
       "      <td>1071</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04244591</th>\n",
       "      <th>Phase 2|Phase 3</th>\n",
       "      <th>80</th>\n",
       "      <th>13-Apr-20</th>\n",
       "      <th>China</th>\n",
       "      <td>139</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04252885</th>\n",
       "      <th>Phase 4</th>\n",
       "      <th>86</th>\n",
       "      <th>31-May-20</th>\n",
       "      <th>China</th>\n",
       "      <td>1060</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04261517</th>\n",
       "      <th>Phase 3</th>\n",
       "      <th>30</th>\n",
       "      <th>25-Feb-20</th>\n",
       "      <th>China</th>\n",
       "      <td>377</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04883203</th>\n",
       "      <th>Phase 3</th>\n",
       "      <th>130</th>\n",
       "      <th>31-Oct-20</th>\n",
       "      <th>Tunisia</th>\n",
       "      <td>177</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04885777</th>\n",
       "      <th>Not Applicable</th>\n",
       "      <th>50</th>\n",
       "      <th>30-Oct-20</th>\n",
       "      <th>Turkey</th>\n",
       "      <td>1113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04894409</th>\n",
       "      <th>Not Applicable</th>\n",
       "      <th>231</th>\n",
       "      <th>29-Sep-20</th>\n",
       "      <th>Mexico</th>\n",
       "      <td>242</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04898088</th>\n",
       "      <th>Not Applicable</th>\n",
       "      <th>30</th>\n",
       "      <th>30-Sep-20</th>\n",
       "      <th>Turkey</th>\n",
       "      <td>57</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT04900129</th>\n",
       "      <th>Phase 1</th>\n",
       "      <th>43</th>\n",
       "      <th>30-Dec-20</th>\n",
       "      <th>Bangladesh</th>\n",
       "      <td>321</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>511 rows × 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                       Rank\n",
       "NCT Number  Phases          Enrollment Completion Date Locations           \n",
       "NCT03852537 Phase 2         44         15-Mar-21        United States  1100\n",
       "NCT04160975 Not Applicable  2902       19-Feb-21        United States  1071\n",
       "NCT04244591 Phase 2|Phase 3 80         13-Apr-20        China           139\n",
       "NCT04252885 Phase 4         86         31-May-20        China          1060\n",
       "NCT04261517 Phase 3         30         25-Feb-20        China           377\n",
       "...                                                                     ...\n",
       "NCT04883203 Phase 3         130        31-Oct-20        Tunisia         177\n",
       "NCT04885777 Not Applicable  50         30-Oct-20        Turkey         1113\n",
       "NCT04894409 Not Applicable  231        29-Sep-20        Mexico          242\n",
       "NCT04898088 Not Applicable  30         30-Sep-20        Turkey           57\n",
       "NCT04900129 Phase 1         43         30-Dec-20        Bangladesh      321\n",
       "\n",
       "[511 rows x 1 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Split up our data into groups based upon 'Phases','Location','Enrollment'\n",
    "Phases_groups = covid_df.groupby(['NCT Number','Phases','Enrollment','Completion Date','Locations'])\n",
    "\n",
    "# Create a new variable that holds the sum of our groups\n",
    "sum_it_up = Phases_groups.sum()\n",
    "sum_it_up.head(1000)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 432x288 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Split up our data into groups based upon 'gender'\n",
    "Phases_groups = covid_df.groupby('Phases')\n",
    "# Find out how many of each Study ID assigned with phases\n",
    "NCT_Number = Phases_groups['Enrollment'].count()\n",
    "# Drop the 'phases' row that is contained within our group\n",
    "NCT_Number = NCT_Number.drop(NCT_Number.index[5])\n",
    "# Chart our data, give it a title, and label the axes\n",
    "Phases_chart = NCT_Number.plot(kind=\"bar\", title=\"Phase by Study ID\")\n",
    "Phases_chart.set_xlabel(\"Phases\")\n",
    "Phases_chart.set_ylabel(\"Number of Studies\")\n",
    "\n",
    "plt.show()\n",
    "plt.tight_layout()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "12000000\n",
      "1\n"
     ]
    }
   ],
   "source": [
    "# Figure out the minimum and maximum Enrollment for all studies\n",
    "print(covid_df[\"Enrollment\"].max())\n",
    "print(covid_df[\"Enrollment\"].min())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create bins in which to place values based upon TED Talk views\n",
    "bins = [0, 199999, 399999, 599999, 799999, 999999,\n",
    "        1999999, 2999999, 3999999, 4999999, 5999999,6999999,7999999,200000000]\n",
    "\n",
    "# Create labels for these bins\n",
    "group_labels = [\"0 to 199k\", \"200k to 399k\", \"400k to 599k\", \"600k to 799k\", \"800k to 999k\", \"1mil to 2mil\",\n",
    "                \"2mil to 3mil\", \"3mil to 4mil\", \"4mil to 5mil\", \"5mil to 6mil\",\"6mil to 7mil\",\"7mil to 8 mil\",\"8mil to 200mil\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    0 to 199k\n",
       "1    0 to 199k\n",
       "2    0 to 199k\n",
       "3    0 to 199k\n",
       "4    0 to 199k\n",
       "Name: Enrollment, dtype: category\n",
       "Categories (13, object): ['0 to 199k' < '200k to 399k' < '400k to 599k' < '600k to 799k' ... '5mil to 6mil' < '6mil to 7mil' < '7mil to 8 mil' < '8mil to 200mil']"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Slice the data and place it into bins\n",
    "pd.cut(covid_df[\"Enrollment\"], bins, labels=group_labels).head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:>"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "covid_df.Enrollment.hist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "      <th>Enrollment Group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Other|NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.4891</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>Spain</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>Portugal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>Pakistan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "      Status         Study Results Conditions  \\\n",
       "0  Completed  No Results Available   COVID-19   \n",
       "1  Completed           Has Results   COVID-19   \n",
       "2  Completed  No Results Available   COVID-19   \n",
       "3  Completed  No Results Available   COVID-19   \n",
       "4  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures Gender  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...    All   \n",
       "1  Change From Baseline in C-reactive Protein (CR...    All   \n",
       "2  To calulate the time of intubation|To calculat...    All   \n",
       "3  Differences in gut microbiota composition betw...    All   \n",
       "4  Percentage of subjects with COVID-19 disease p...    All   \n",
       "\n",
       "                                           Age   Phases  Enrollment  \\\n",
       "0    18 Years and older   (Adult, Older Adult)  Phase 2          17   \n",
       "1  18 Years to 70 Years   (Adult, Older Adult)  Phase 2         206   \n",
       "2    18 Years and older   (Adult, Older Adult)  Phase 2         495   \n",
       "3    18 Years and older   (Adult, Older Adult)      NaN         115   \n",
       "4    18 Years and older   (Adult, Older Adult)  Phase 3         152   \n",
       "\n",
       "       Funded Bys      Study Type Start Date Completion Date First Posted  \\\n",
       "0       Other|NIH  Interventional   1-Jun-20       22-Jan-21    11-Jun-20   \n",
       "1  Industry|Other  Interventional  21-Jul-20       13-Oct-20    30-Jun-20   \n",
       "2  Other|Industry  Interventional  22-May-20       23-Dec-20    24-Jun-20   \n",
       "3           Other   Observational  20-Apr-20       16-Jul-20    21-Apr-20   \n",
       "4           Other  Interventional  29-Sep-20       15-Apr-21     8-Oct-20   \n",
       "\n",
       "         Locations p-values Enrollment Group  \n",
       "0    United States      NaN        0 to 199k  \n",
       "1   United Kingdom   0.4891        0 to 199k  \n",
       "2            Spain      NaN        0 to 199k  \n",
       "3         Portugal      NaN        0 to 199k  \n",
       "4         Pakistan      NaN        0 to 199k  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Place the data series into a new column inside of the DataFrame\n",
    "covid_df[\"Enrollment Group\"] = pd.cut(covid_df[\"Enrollment\"], bins, labels=group_labels)\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Enrollment Group\n",
      "0 to 199k         510\n",
      "200k to 399k        0\n",
      "400k to 599k        1\n",
      "600k to 799k        0\n",
      "800k to 999k        0\n",
      "1mil to 2mil        0\n",
      "2mil to 3mil        0\n",
      "3mil to 4mil        0\n",
      "4mil to 5mil        0\n",
      "5mil to 6mil        0\n",
      "6mil to 7mil        0\n",
      "7mil to 8 mil       0\n",
      "8mil to 200mil      0\n",
      "Name: Phases, dtype: int64\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "      <th>Enrollment Group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Other|NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.4891</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>Spain</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>Portugal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>Pakistan</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0 to 199k</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>43</td>\n",
       "      <td>NCT04331171</td>\n",
       "      <td>Epidemiological Observation From a Smartphone ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Device: Web application users</td>\n",
       "      <td>To assess of the evolution of the number of ca...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12000000</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>17-Mar-20</td>\n",
       "      <td>15-Nov-20</td>\n",
       "      <td>2-Apr-20</td>\n",
       "      <td>France</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8mil to 200mil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>260</td>\n",
       "      <td>NCT04460274</td>\n",
       "      <td>Forecast Number of Covid-19 Cases Worldwide</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Covid-19</td>\n",
       "      <td>Other: Model Building|Other: Model validation</td>\n",
       "      <td>Number of Confirmed cases of Covid-19</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7882471</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>31-Dec-19</td>\n",
       "      <td>20-Jun-20</td>\n",
       "      <td>7-Jul-20</td>\n",
       "      <td>Turkey</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7mil to 8 mil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>792</th>\n",
       "      <td>793</td>\n",
       "      <td>NCT04407117</td>\n",
       "      <td>Appendicitis During the National Lockdown Duri...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Appendicitis</td>\n",
       "      <td>Behavioral: Lock-down and social distancing</td>\n",
       "      <td>Appendectomy|Postoperative length of stay|Mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6000000</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>23-Mar-17</td>\n",
       "      <td>19-Apr-20</td>\n",
       "      <td>29-May-20</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6mil to 7mil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>890</th>\n",
       "      <td>891</td>\n",
       "      <td>NCT04891276</td>\n",
       "      <td>Impact of COVID-19 Infection and Confinement o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Diabetic Subjects With Hospital Stays</td>\n",
       "      <td>Other: Data collection</td>\n",
       "      <td>Frequency of lower limb amputations</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3300000</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>16-Oct-20</td>\n",
       "      <td>14-Apr-21</td>\n",
       "      <td>18-May-21</td>\n",
       "      <td>France</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3mil to 4mil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>901</th>\n",
       "      <td>902</td>\n",
       "      <td>NCT04370886</td>\n",
       "      <td>Recruit Blood Donors Via SMS During Epidemic o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Blood Donation</td>\n",
       "      <td>Behavioral: blood donation SMS</td>\n",
       "      <td>Blood donation rate</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 60 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>456517</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>30-Apr-20</td>\n",
       "      <td>10-May-20</td>\n",
       "      <td>1-May-20</td>\n",
       "      <td>China</td>\n",
       "      <td>NaN</td>\n",
       "      <td>400k to 599k</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Rank   NCT Number                                              Title  \\\n",
       "0       1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1       2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2       3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3       4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4       5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "42     43  NCT04331171  Epidemiological Observation From a Smartphone ...   \n",
       "259   260  NCT04460274        Forecast Number of Covid-19 Cases Worldwide   \n",
       "792   793  NCT04407117  Appendicitis During the National Lockdown Duri...   \n",
       "890   891  NCT04891276  Impact of COVID-19 Infection and Confinement o...   \n",
       "901   902  NCT04370886  Recruit Blood Donors Via SMS During Epidemic o...   \n",
       "\n",
       "        Status         Study Results                             Conditions  \\\n",
       "0    Completed  No Results Available                               COVID-19   \n",
       "1    Completed           Has Results                               COVID-19   \n",
       "2    Completed  No Results Available                               COVID-19   \n",
       "3    Completed  No Results Available                               COVID-19   \n",
       "4    Completed  No Results Available                               COVID-19   \n",
       "42   Completed  No Results Available                               COVID-19   \n",
       "259  Completed  No Results Available                               Covid-19   \n",
       "792  Completed  No Results Available                           Appendicitis   \n",
       "890  Completed  No Results Available  Diabetic Subjects With Hospital Stays   \n",
       "901  Completed  No Results Available                         Blood Donation   \n",
       "\n",
       "                                         Interventions  \\\n",
       "0                                     Drug: Infliximab   \n",
       "1                              Drug: C21|Drug: Placebo   \n",
       "2                                    Drug: Tocilizumab   \n",
       "3                                      Other: Exposure   \n",
       "4    Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "42                       Device: Web application users   \n",
       "259      Other: Model Building|Other: Model validation   \n",
       "792        Behavioral: Lock-down and social distancing   \n",
       "890                             Other: Data collection   \n",
       "901                     Behavioral: blood donation SMS   \n",
       "\n",
       "                                      Outcome Measures Gender  \\\n",
       "0    Time to improvement in oxygenation|28-day mort...    All   \n",
       "1    Change From Baseline in C-reactive Protein (CR...    All   \n",
       "2    To calulate the time of intubation|To calculat...    All   \n",
       "3    Differences in gut microbiota composition betw...    All   \n",
       "4    Percentage of subjects with COVID-19 disease p...    All   \n",
       "42   To assess of the evolution of the number of ca...    All   \n",
       "259              Number of Confirmed cases of Covid-19    All   \n",
       "792  Appendectomy|Postoperative length of stay|Mort...    All   \n",
       "890                Frequency of lower limb amputations    All   \n",
       "901                                Blood donation rate    All   \n",
       "\n",
       "                                             Age          Phases  Enrollment  \\\n",
       "0      18 Years and older   (Adult, Older Adult)         Phase 2          17   \n",
       "1    18 Years to 70 Years   (Adult, Older Adult)         Phase 2         206   \n",
       "2      18 Years and older   (Adult, Older Adult)         Phase 2         495   \n",
       "3      18 Years and older   (Adult, Older Adult)             NaN         115   \n",
       "4      18 Years and older   (Adult, Older Adult)         Phase 3         152   \n",
       "42     18 Years and older   (Adult, Older Adult)             NaN    12000000   \n",
       "259                    Child, Adult, Older Adult             NaN     7882471   \n",
       "792                    Child, Adult, Older Adult             NaN     6000000   \n",
       "890                    Child, Adult, Older Adult             NaN     3300000   \n",
       "901               18 Years to 60 Years   (Adult)  Not Applicable      456517   \n",
       "\n",
       "         Funded Bys      Study Type Start Date Completion Date First Posted  \\\n",
       "0         Other|NIH  Interventional   1-Jun-20       22-Jan-21    11-Jun-20   \n",
       "1    Industry|Other  Interventional  21-Jul-20       13-Oct-20    30-Jun-20   \n",
       "2    Other|Industry  Interventional  22-May-20       23-Dec-20    24-Jun-20   \n",
       "3             Other   Observational  20-Apr-20       16-Jul-20    21-Apr-20   \n",
       "4             Other  Interventional  29-Sep-20       15-Apr-21     8-Oct-20   \n",
       "42   Other|Industry   Observational  17-Mar-20       15-Nov-20     2-Apr-20   \n",
       "259           Other   Observational  31-Dec-19       20-Jun-20     7-Jul-20   \n",
       "792           Other   Observational  23-Mar-17       19-Apr-20    29-May-20   \n",
       "890           Other   Observational  16-Oct-20       14-Apr-21    18-May-21   \n",
       "901           Other  Interventional  30-Apr-20       10-May-20     1-May-20   \n",
       "\n",
       "           Locations p-values Enrollment Group  \n",
       "0      United States      NaN        0 to 199k  \n",
       "1     United Kingdom   0.4891        0 to 199k  \n",
       "2              Spain      NaN        0 to 199k  \n",
       "3           Portugal      NaN        0 to 199k  \n",
       "4           Pakistan      NaN        0 to 199k  \n",
       "42            France      NaN   8mil to 200mil  \n",
       "259           Turkey      NaN    7mil to 8 mil  \n",
       "792          Denmark      NaN     6mil to 7mil  \n",
       "890           France      NaN     3mil to 4mil  \n",
       "901            China      NaN     400k to 599k  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Create a GroupBy object based upon \"Phase Group\"\n",
    "Enrollment_Group = covid_df.groupby(\"Enrollment Group\")\n",
    "\n",
    "# Find how many rows fall into each bin\n",
    "print(Enrollment_Group[\"Phases\"].count())\n",
    "\n",
    "# Get the average of each column within the GroupBy object\n",
    "Enrollment_Group[[\"Enrollment\",\"Start Date\"]].mean()\n",
    "Enrollment_Group.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Labels for the sections (phases) of our pie chart for total studies\n",
    "labels = [\"Phase 1\", \"Phase 2\", \"Phase 3\",\"Phase 4\"]\n",
    "\n",
    "# The values of each section of the pie chart\n",
    "sizes =[80,95,100,220]\n",
    "\n",
    "# The colors of each section of the pie chart\n",
    "colors = [\"red\", \"orange\", \"lightcoral\", \"lightskyblue\"]\n",
    "\n",
    "# Tells matplotlib to seperate the \"Phase 4\" section from the others\n",
    "explode = (0.1, 0, 0, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "([<matplotlib.patches.Wedge at 0x7f8d7c8e3fd0>,\n",
       "  <matplotlib.patches.Wedge at 0x7f8d7c8f0940>,\n",
       "  <matplotlib.patches.Wedge at 0x7f8d7c8fc250>,\n",
       "  <matplotlib.patches.Wedge at 0x7f8d7c8fcb20>],\n",
       " [Text(-1.1783144366078604, 0.22710149378967348, 'Phase 1'),\n",
       "  Text(-0.6661706546096903, -0.8753380255289364, 'Phase 2'),\n",
       "  Text(0.609312062457639, -0.9158268452844228, 'Phase 3'),\n",
       "  Text(0.5500000099101631, 0.9526279384412472, 'Phase 4')],\n",
       " [Text(-0.6873500880212517, 0.1324758713773095, '16.2%'),\n",
       "  Text(-0.3633658116052855, -0.47745710483396525, '19.2%'),\n",
       "  Text(0.33235203406780306, -0.49954191560968514, '20.2%'),\n",
       "  Text(0.30000000540554345, 0.5196152391497711, '44.4%')])"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Creates the pie chart based upon the values above\n",
    "# Automatically finds the percentages of each part of the pie chart\n",
    "plt.pie(sizes, explode=explode, labels=labels, colors=colors,\n",
    "        autopct=\"%1.1f%%\", shadow=True, startangle=140)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "#lsit top 5 drugs and relate phase number\n",
    "#calculate the average data collected from Datasource\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Labels for the sections (phases) of our pie chart for total studies\n",
    "labels = [\"No Results Available\", \"Has Results\"]\n",
    "\n",
    "# The values of each section of the pie chart\n",
    "sizes =[220,60]\n",
    "\n",
    "# The colors of each section of the pie chart\n",
    "colors = [\"lightcoral\", \"lightskyblue\"]\n",
    "\n",
    "# Tells matplotlib to seperate the \"Has Results\" section from the others\n",
    "explode = (0.1, 0,)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "([<matplotlib.patches.Wedge at 0x7f8d7cc1f280>,\n",
       "  <matplotlib.patches.Wedge at 0x7f8d7cc1fbb0>],\n",
       " [Text(0.23777530891102117, -1.1762069981394725, 'No Results Available'),\n",
       "  Text(-0.2179606493613971, 1.078189758497992, 'Has Results')],\n",
       " [Text(0.138702263531429, -0.6861207489146921, '78.6%'),\n",
       "  Text(-0.11888762692439842, 0.5881035046352683, '21.4%')])"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Creates the pie chart based upon the values above\n",
    "# Automatically finds the percentages of each part of the pie chart\n",
    "plt.pie(sizes, explode=explode, labels=labels, colors=colors,\n",
    "        autopct=\"%1.1f%%\", shadow=True, startangle=140)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
